Janet Dorling
Corporate Officer/Principal bij GILEAD SCIENCES, INC.
Profiel
Janet Dorling is on the board of Gilead Sciences Belgium BV and Senior VP- Intercontinental Region at Gilead Sciences, Inc.
In her past career Ms. Dorling held the position of VP-Breast Cancer Franchise & Global Product at Roche Holding AG, Chief Commercial Officer at CymaBay Therapeutics, Inc. and Chief Commercial Officer at Achaogen, Inc.
Janet Dorling received an MBA from the University of California, Berkeley, a graduate degree from Duke University and an MBA from Haas School of Business.
Actieve functies van Janet Dorling
Bedrijven | Functie | Begin |
---|---|---|
GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01-05-2020 |
Gilead Sciences Belgium BV
Gilead Sciences Belgium BV Medical DistributorsDistribution Services Gilead Sciences Belgium BV is a Belgian company that was founded in 2006. The private company is based in Machelen, Belgium. The company provides a portal for healthcare professionals under the name Gilead Sciences. | Director/Board Member | 01-02-2023 |
Eerdere bekende functies van Janet Dorling
Bedrijven | Functie | Einde |
---|---|---|
CYMABAY THERAPEUTICS, INC. | Director/Board Member | 22-03-2024 |
CYMABAY THERAPEUTICS, INC. | Corporate Officer/Principal | 01-12-2019 |
ACHAOGEN | Corporate Officer/Principal | 30-06-2019 |
ROCHE HOLDING AG | Corporate Officer/Principal | 01-01-2017 |
Opleiding van Janet Dorling
Duke University | Graduate Degree |
University of California, Berkeley | Masters Business Admin |
Haas School of Business | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
GILEAD SCIENCES, INC. | Health Technology |
ROCHE HOLDING AG | Health Technology |
CYMABAY THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Achaogen, Inc.
Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
Gilead Sciences Belgium BV
Gilead Sciences Belgium BV Medical DistributorsDistribution Services Gilead Sciences Belgium BV is a Belgian company that was founded in 2006. The private company is based in Machelen, Belgium. The company provides a portal for healthcare professionals under the name Gilead Sciences. | Distribution Services |